Screener / SEC EDGAR /CIK 0001295947 /10-K filed May 14, 2026, compared with May 9, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Pharmaceuticals

Prestige Consumer Healthcare Inc. PBH

Compare with peers Embed

PBH among the 162 companies we cover

Where it stands · the better end on the right. The band holds the middle half; the line is the median.

All 162
Sales growth
+4.8%+20.2%
-4.3%147th of 155 · median +10.5%
Net margin
-4.1%15.3%
13.3%51st of 154 · median 6.8%
Return on equity
-5.2%18.5%
8.0%78th of 144 · median 9.2%
Free cash flow margin
2.3%19.2%
18.4%40th of 145 · median 10.0%
Debt / equity (less is better)
1.160.42
1.0778th of 108 · median 0.69

PBH and 9 peers, year by year

The 9 Health care companies closest to PBH in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

Choose the peers

Health care companies (up to 9):

Each company's latest fiscal year
CompanyYearRevenueSales growthGross marginOperating marginNet marginFCF marginReturn on equityDebt / equity
PBH Prestige Consumer Healthcare Inc. FY2026 $1.1B−4.3%54.7%28.4%17.5%22.6%10.1%0.53
ACAD Acadia Pharmaceuticals Inc FY2025 $1.1B+11.9%-9.8%36.5%9.8%31.9%-
TECH Bio-Techne FY2026 $1.2B−0.4%65.8%20.7%15.0%21.7%8.6%0.09
SHC Sotera Health Co FY2025 $1.2B+5.7%55.5%-6.7%12.8%12.9%3.53
GH Guardant Health, Inc. FY2025 $982.0M+32.9%-−44.5%−42.4%−23.7%n/mn/m
CAI Caris Life Sciences, Inc. FY2025 $812.0M+97.0%-5.6%−8.4%8.2%−11.8%0.66
PGNY Progyny, Inc. FY2025 $1.3B+10.4%23.6%6.6%4.5%14.9%11.3%-
CORT Corcept Therapeutics Inc FY2025 $761.4M+12.8%-5.9%13.1%18.6%15.4%-
BCRX Biocryst Pharmaceuticals Inc FY2025 $874.8M+94.1%-39.0%30.2%39.4%n/mn/m
IONS Ionis Pharmaceuticals Inc FY2025 $943.7M+33.8%-−40.4%−40.4%−33.9%−78.0%3.71

Each company, year by year

Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2017 to FY2026 · 10-K XBRL

PBHPrestige Consumer Healthcare Inc.
FY2017 revenue $882.1MFY2018 revenue $1.0BFY2019 revenue $975.8MFY2020 revenue $963.0MFY2021 revenue $943.4MFY2022 revenue $1.1BFY2023 revenue $1.1BFY2024 revenue $1.1BFY2025 revenue $1.1BFY2026 revenue $1.1B FY2017 net margin 7.9%FY2018 net margin 32.6%FY2019 net margin −3.7%FY2020 net margin 14.8%FY2021 net margin 17.5%FY2022 net margin 18.9%FY2023 net margin −7.3%FY2024 net margin 18.6%FY2025 net margin 18.9%FY2026 net margin 17.5% FY2017FY2026
Revenue$1.1B Growth−4.3% Net margin17.5%
ACADAcadia Pharmaceuticals Inc
FY2017 revenue $124.9MFY2018 revenue $223.8MFY2019 revenue $339.1MFY2020 revenue $441.8MFY2021 revenue $484.1MFY2022 revenue $517.2MFY2023 revenue $726.4MFY2024 revenue $957.8MFY2025 revenue $1.1B FY2017 net margin −231.7%FY2018 net margin −109.6%FY2019 net margin −69.4%FY2020 net margin −63.7%FY2021 net margin −34.7%FY2022 net margin −41.8%FY2023 net margin −8.4%FY2024 net margin 23.6%FY2025 net margin 36.5% FY2017FY2026
Revenue$1.1B Growth+11.9% Net margin36.5%
TECHBio-Techne
FY2017 revenue $563.0MFY2018 revenue $643.0MFY2019 revenue $714.0MFY2020 revenue $738.7MFY2021 revenue $931.0MFY2022 revenue $1.1BFY2023 revenue $1.1BFY2024 revenue $1.2BFY2025 revenue $1.2BFY2026 revenue $1.2B FY2017 net margin 13.5%FY2018 net margin 19.6%FY2019 net margin 13.5%FY2020 net margin 31.0%FY2021 net margin 15.1%FY2022 net margin 24.6%FY2023 net margin 25.1%FY2024 net margin 14.5%FY2025 net margin 6.0%FY2026 net margin 15.0% FY2017FY2026
Revenue$1.2B Growth−0.4% Net margin15.0%
SHCSotera Health Co
FY2019 revenue $778.3MFY2020 revenue $818.2MFY2021 revenue $931.5MFY2022 revenue $1.0BFY2023 revenue $1.0BFY2024 revenue $1.1BFY2025 revenue $1.2B FY2019 net margin −2.7%FY2020 net margin −4.7%FY2021 net margin 12.5%FY2022 net margin −23.3%FY2023 net margin 4.9%FY2024 net margin 4.0%FY2025 net margin 6.7% FY2017FY2026
Revenue$1.2B Growth+5.7% Net margin6.7%
GHGuardant Health, Inc.
FY2017 revenue $49.8MFY2018 revenue $90.6MFY2019 revenue $214.4MFY2020 revenue $286.7MFY2021 revenue $373.7MFY2022 revenue $449.5MFY2023 revenue $563.9MFY2024 revenue $739.0MFY2025 revenue $982.0M FY2017 net margin −167.0%FY2018 net margin −93.8%FY2019 net margin −35.3%FY2020 net margin −88.5%FY2021 net margin −103.0%FY2022 net margin −145.6%FY2023 net margin −85.0%FY2024 net margin −59.0%FY2025 net margin −42.4% FY2017FY2026
Revenue$982.0M Growth+32.9% Net margin−42.4%
CAICaris Life Sciences, Inc.
FY2023 revenue $306.1MFY2024 revenue $412.3MFY2025 revenue $812.0M FY2023 net margin −111.5%FY2024 net margin −68.4%FY2025 net margin −8.4% FY2017FY2026
Revenue$812.0M Growth+97.0% Net margin−8.4%
PGNYProgyny, Inc.
FY2017 revenue $48.6MFY2018 revenue $105.4MFY2019 revenue $229.7MFY2020 revenue $344.9MFY2021 revenue $500.6MFY2022 revenue $786.9MFY2023 revenue $1.1BFY2024 revenue $1.2BFY2025 revenue $1.3B FY2017 net margin −25.6%FY2018 net margin 0.6%FY2019 net margin −3.7%FY2020 net margin 13.5%FY2021 net margin 13.1%FY2022 net margin 3.9%FY2023 net margin 5.7%FY2024 net margin 4.7%FY2025 net margin 4.5% FY2017FY2026
Revenue$1.3B Growth+10.4% Net margin4.5%
CORTCorcept Therapeutics Inc
FY2017 revenue $159.2MFY2018 revenue $251.2MFY2019 revenue $306.5MFY2020 revenue $353.9MFY2021 revenue $366.0MFY2022 revenue $401.9MFY2023 revenue $482.4MFY2024 revenue $675.0MFY2025 revenue $761.4M FY2017 net margin 81.1%FY2018 net margin 30.0%FY2019 net margin 30.7%FY2020 net margin 30.0%FY2021 net margin 30.7%FY2022 net margin 25.2%FY2023 net margin 22.0%FY2024 net margin 20.9%FY2025 net margin 13.1% FY2017FY2026
Revenue$761.4M Growth+12.8% Net margin13.1%
BCRXBiocryst Pharmaceuticals Inc
FY2017 revenue $25.2MFY2018 revenue $20.7MFY2019 revenue $48.8MFY2020 revenue $17.8MFY2021 revenue $157.2MFY2022 revenue $270.8MFY2023 revenue $331.4MFY2024 revenue $450.7MFY2025 revenue $874.8M FY2017 net margin −261.2%FY2018 net margin −490.3%FY2019 net margin −223.0%FY2021 net margin −117.1%FY2022 net margin −91.2%FY2023 net margin −68.4%FY2024 net margin −19.7%FY2025 net margin 30.2% FY2017FY2026
Revenue$874.8M Growth+94.1% Net margin30.2%
IONSIonis Pharmaceuticals Inc
FY2017 revenue $514.2MFY2018 revenue $599.7MFY2019 revenue $1.1BFY2020 revenue $729.3MFY2021 revenue $810.5MFY2022 revenue $587.4MFY2023 revenue $787.6MFY2024 revenue $705.1MFY2025 revenue $943.7M FY2017 net margin 0.1%FY2018 net margin 45.6%FY2019 net margin 24.8%FY2020 net margin −60.9%FY2021 net margin −3.5%FY2022 net margin −45.9%FY2023 net margin −46.5%FY2024 net margin −64.4%FY2025 net margin −40.4% FY2017FY2026
Revenue$943.7M Growth+33.8% Net margin−40.4%

Who rewrote the most

Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before

Risk FactorsMD&AEach company's latest 10-K, so the dates differ. A company that rewrote much may have reorganized the text.

Revenue, FY2017 to FY2026

Revenue as reported in the 10-K.

100 200 500 1000 2000 FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026 ACAD: $124.9M, $223.8M, $339.1M, $441.8M, $484.1M, $517.2M, $726.4M, $957.8M, $1.1B, - ACAD TECH: $563.0M, $643.0M, $714.0M, $738.7M, $931.0M, $1.1B, $1.1B, $1.2B, $1.2B, $1.2B TECH SHC: -, -, $778.3M, $818.2M, $931.5M, $1.0B, $1.0B, $1.1B, $1.2B, - SHC GH: $49.8M, $90.6M, $214.4M, $286.7M, $373.7M, $449.5M, $563.9M, $739.0M, $982.0M, - GH CAI: -, -, -, -, -, -, $306.1M, $412.3M, $812.0M, - CAI PGNY: $48.6M, $105.4M, $229.7M, $344.9M, $500.6M, $786.9M, $1.1B, $1.2B, $1.3B, - PGNY CORT: $159.2M, $251.2M, $306.5M, $353.9M, $366.0M, $401.9M, $482.4M, $675.0M, $761.4M, - CORT BCRX: $25.2M, $20.7M, $48.8M, $17.8M, $157.2M, $270.8M, $331.4M, $450.7M, $874.8M, - BCRX IONS: $514.2M, $599.7M, $1.1B, $729.3M, $810.5M, $587.4M, $787.6M, $705.1M, $943.7M, - IONS PBH: $882.1M, $1.0B, $975.8M, $963.0M, $943.4M, $1.1B, $1.1B, $1.1B, $1.1B, $1.1B PBH
PBH is the bold green line; each peer has its own colour and dash, named at the line's end. Each company's first year in the window is 100, on a log scale: a line twice as high has doubled. A gap is a year with no number. A ring marks where a line starts: SHC, CAI have no earlier 10-K here.

Sales growth, FY2017 to FY2026

Revenue against the fiscal year before.

−63.5% +782% FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026 ACAD: +621%, +79.2%, +51.5%, +30.3%, +9.6%, +6.8%, +40.4%, +31.8%, +11.9%, - ACAD TECH: +12.8%, +14.2%, +11.0%, +3.5%, +26.0%, +18.7%, +2.8%, +2.0%, +5.2%, −0.4% TECH SHC: -, -, -, +5.1%, +13.9%, +7.8%, +4.5%, +4.9%, +5.7%, - SHC GH: +97.4%, +81.9%, +137%, +33.8%, +30.3%, +20.3%, +25.5%, +31.0%, +32.9%, - GH CAI: -, -, -, -, -, -, -, +34.7%, +97.0%, - CAI PGNY: -, +117%, +118%, +50.1%, +45.2%, +57.2%, +38.3%, +7.2%, +10.4%, - PGNY CORT: +95.8%, +57.8%, +22.0%, +15.5%, +3.4%, +9.8%, +20.0%, +39.9%, +12.8%, - CORT BCRX: −4.4%, −18.0%, +136%, −63.5%, +782%, +72.3%, +22.4%, +36.0%, +94.1%, - BCRX IONS: +37.9%, +16.6%, +87.2%, −35.0%, +11.1%, −27.5%, +34.1%, −10.5%, +33.8%, - IONS PBH: +9.4%, +18.0%, −6.3%, −1.3%, −2.0%, +15.2%, +3.8%, −0.2%, +1.1%, −4.3% PBH
PBH is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −63.5% to +782%. A gap is a year with no number. A ring marks where a line starts: SHC, CAI, PGNY have no earlier 10-K here.

Gross margin, FY2017 to FY2026

Gross profit / revenue.

15.2% 98.0% FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026 ACAD: 92.7%, 94.5%, 96.7%, 97.7%, 97.8%, 98.0%, 94.3%, -, -, - ACAD TECH: 66.5%, 67.2%, 66.3%, 65.4%, 68.0%, 68.4%, 67.7%, 66.4%, 64.8%, 65.8% TECH SHC: -, -, 50.8%, 54.2%, 55.7%, 55.5%, 55.0%, 54.7%, 55.5%, - SHC PGNY: 15.2%, 18.4%, 19.8%, 20.3%, 22.4%, 21.3%, 21.9%, 21.7%, 23.6%, - PGNY PBH: 56.7%, 55.4%, 56.9%, 57.3%, 58.0%, 57.1%, 55.4%, 55.5%, 55.8%, 54.7% PBH
PBH is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 15.2% to 98.0%. A gap is a year with no number. A ring marks where a line starts: SHC has no earlier 10-K here.
CompanyFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
PBH Mar 56.7%55.4%56.9%57.3%58.0%57.1%55.4%55.5%55.8%54.7%
ACAD Dec 92.7%94.5%96.7%97.7%97.8%98.0%94.3%---
TECH Jun 66.5%67.2%66.3%65.4%68.0%68.4%67.7%66.4%64.8%65.8%
SHC Dec --50.8%54.2%55.7%55.5%55.0%54.7%55.5%-
GH Dec ----------
CAI Dec ----------
PGNY Dec 15.2%18.4%19.8%20.3%22.4%21.3%21.9%21.7%23.6%-
CORT Dec ----------
BCRX Dec ----------
IONS Dec ----------
Peer median66.5%67.2%58.6%59.8%61.8%62.0%61.4%54.7%55.5%-

Operating margin, FY2017 to FY2026

Operating income / revenue.

−981.1% 39.0% FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026 ACAD: −234.1%, −110.6%, −72.7%, −64.9%, −35.2%, −43.2%, −10.1%, 24.1%, 9.8%, - ACAD TECH: 21.4%, 21.2%, 20.5%, 21.3%, 25.5%, 26.8%, 26.3%, 17.8%, 8.4%, 20.7% TECH SHC: -, -, 23.6%, 25.2%, 27.6%, 24.7%, 26.4%, 27.0%, -, - SHC GH: −153.7%, −102.5%, −38.4%, −88.9%, −110.0%, −121.1%, −100.1%, −60.0%, −44.5%, - GH CAI: -, -, -, -, -, -, −104.4%, −62.4%, 5.6%, - CAI PGNY: −22.7%, −3.3%, 4.2%, 2.4%, 6.5%, 3.0%, 5.7%, 5.8%, 6.6%, - PGNY CORT: 33.2%, 35.6%, 36.4%, 36.2%, 34.0%, 28.0%, 22.2%, 20.3%, 5.9%, - CORT BCRX: −227.9%, −456.2%, −203.7%, −981.1%, −113.1%, −54.8%, −31.3%, −0.6%, 39.0%, - BCRX IONS: 6.0%, −10.2%, 32.6%, −23.6%, −3.7%, −69.8%, −44.9%, −67.4%, −40.4%, - IONS PBH: 23.3%, 20.7%, 6.9%, 30.2%, 31.5%, 30.4%, −2.0%, 30.4%, 29.6%, 28.4% PBH
PBH is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −981.1% to 39.0%. A gap is a year with no number. A ring marks where a line starts: SHC, CAI have no earlier 10-K here.

Net margin, FY2017 to FY2026

Net income / revenue.

−490.3% 81.1% FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026 ACAD: −231.7%, −109.6%, −69.4%, −63.7%, −34.7%, −41.8%, −8.4%, 23.6%, 36.5%, - ACAD TECH: 13.5%, 19.6%, 13.5%, 31.0%, 15.1%, 24.6%, 25.1%, 14.5%, 6.0%, 15.0% TECH SHC: -, -, −2.7%, −4.7%, 12.5%, −23.3%, 4.9%, 4.0%, 6.7%, - SHC GH: −167.0%, −93.8%, −35.3%, −88.5%, −103.0%, −145.6%, −85.0%, −59.0%, −42.4%, - GH CAI: -, -, -, -, -, -, −111.5%, −68.4%, −8.4%, - CAI PGNY: −25.6%, 0.6%, −3.7%, 13.5%, 13.1%, 3.9%, 5.7%, 4.7%, 4.5%, - PGNY CORT: 81.1%, 30.0%, 30.7%, 30.0%, 30.7%, 25.2%, 22.0%, 20.9%, 13.1%, - CORT BCRX: −261.2%, −490.3%, −223.0%, n/m, −117.1%, −91.2%, −68.4%, −19.7%, 30.2%, - BCRX IONS: 0.1%, 45.6%, 24.8%, −60.9%, −3.5%, −45.9%, −46.5%, −64.4%, −40.4%, - IONS PBH: 7.9%, 32.6%, −3.7%, 14.8%, 17.5%, 18.9%, −7.3%, 18.6%, 18.9%, 17.5% PBH
PBH is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −490.3% to 81.1%. A gap is a year with no number. A ring marks where a line starts: SHC, CAI have no earlier 10-K here.

Free cash flow, FY2017 to FY2026

Cash from operations minus capital spending.

−$546.2M $589.3M FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026 ACAD: −$218.6M, −$169.6M, −$152.3M, −$143.8M, −$126.8M, −$114.0M, $16.7M, $157.2M, $105.1M, - ACAD TECH: $128.5M, $149.4M, $156.2M, $153.5M, $307.9M, $280.4M, $216.1M, $236.1M, $256.6M, $263.2M TECH SHC: -, -, $91.8M, $67.1M, $179.4M, $95.6M, −$362.7M, $45.1M, $149.2M, - SHC GH: −$78.9M, −$92.4M, −$65.9M, −$140.1M, −$284.1M, −$386.9M, −$345.5M, −$274.9M, −$233.1M, - GH CAI: -, -, -, -, -, -, −$298.4M, −$253.6M, $66.9M, - CAI PGNY: −$10.1M, $1.7M, −$4.5M, $35.2M, $23.9M, $77.2M, $185.2M, $173.7M, $191.8M, - PGNY CORT: $60.5M, $115.4M, $135.0M, $150.7M, $167.4M, $119.9M, $126.5M, $196.1M, $141.8M, - CORT BCRX: −$41.5M, −$92.9M, −$89.9M, −$135.6M, −$144.5M, −$163.2M, −$97.3M, −$53.1M, $344.9M, - BCRX IONS: $139.4M, $589.3M, $314.7M, $772K, $18.8M, −$290.1M, −$331.3M, −$546.2M, −$320.0M, - IONS PBH: $145.7M, $197.6M, $178.8M, $202.6M, $213.4M, $250.3M, $221.9M, $239.4M, $243.3M, $246.4M PBH
PBH is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$546.2M to $589.3M. A gap is a year with no number. A ring marks where a line starts: SHC, CAI have no earlier 10-K here.

FCF margin, FY2017 to FY2026

Free cash flow / revenue.

−761.4% 98.3% FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026 ACAD: −175.0%, −75.8%, −44.9%, −32.5%, −26.2%, −22.0%, 2.3%, 16.4%, 9.8%, - ACAD TECH: 22.8%, 23.2%, 21.9%, 20.8%, 33.1%, 25.4%, 19.0%, 20.4%, 21.0%, 21.7% TECH SHC: -, -, 11.8%, 8.2%, 19.3%, 9.5%, −34.6%, 4.1%, 12.8%, - SHC GH: −158.3%, −101.9%, −30.7%, −48.9%, −76.0%, −86.1%, −61.3%, −37.2%, −23.7%, - GH CAI: -, -, -, -, -, -, −97.5%, −61.5%, 8.2%, - CAI PGNY: −20.8%, 1.6%, −2.0%, 10.2%, 4.8%, 9.8%, 17.0%, 14.9%, 14.9%, - PGNY CORT: 38.0%, 45.9%, 44.1%, 42.6%, 45.7%, 29.8%, 26.2%, 29.1%, 18.6%, - CORT BCRX: −164.7%, −450.0%, −184.1%, −761.4%, −92.0%, −60.3%, −29.4%, −11.8%, 39.4%, - BCRX IONS: 27.1%, 98.3%, 28.0%, 0.1%, 2.3%, −49.4%, −42.1%, −77.5%, −33.9%, - IONS PBH: 16.5%, 19.0%, 18.3%, 21.0%, 22.6%, 23.0%, 19.7%, 21.3%, 21.4%, 22.6% PBH
PBH is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −761.4% to 98.3%. A gap is a year with no number. A ring marks where a line starts: SHC, CAI have no earlier 10-K here.

Return on equity, FY2017 to FY2026

Net income / shareholders' equity at the year end.

−94.7% 67.6% FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026 ACAD: −86.3%, −51.2%, −33.7%, −44.9%, −31.0%, −53.9%, −14.2%, 30.9%, 31.9%, - ACAD TECH: 8.0%, 11.7%, 8.2%, 16.6%, 9.0%, 16.0%, 14.5%, 8.1%, 3.8%, 8.6% TECH SHC: -, -, n/m, −8.5%, 19.9%, −66.7%, 11.6%, 11.0%, 12.9%, - SHC GH: −27.0%, −17.6%, −9.5%, −19.5%, −59.7%, n/m, n/m, n/m, n/m, - GH CAI: -, -, -, -, -, -, n/m, n/m, −11.8%, - CAI PGNY: n/m, n/m, −7.5%, 27.8%, 26.1%, 8.1%, 11.2%, 12.9%, 11.3%, - PGNY CORT: 67.6%, 27.3%, 25.4%, 20.3%, 29.9%, 20.2%, 20.9%, 20.8%, 15.4%, - CORT BCRX: −78.5%, n/m, n/m, n/m, n/m, n/m, n/m, n/m, n/m, - BCRX IONS: 0.1%, 26.1%, 18.9%, −59.8%, −3.7%, −47.1%, −94.7%, −77.1%, −78.0%, - IONS PBH: 8.4%, 28.8%, −3.3%, 12.2%, 12.1%, 13.0%, −5.7%, 12.6%, 11.7%, 10.1% PBH
PBH is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −94.7% to 67.6%. A gap is a year with no number. A ring marks where a line starts: SHC, CAI, PGNY have no earlier 10-K here.

Debt / equity, FY2017 to FY2026

Total debt / shareholders' equity at the year end.

0.00 5.55 FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026 TECH: 0.36, 0.31, 0.43, 0.26, 0.22, 0.15, 0.18, 0.15, 0.18, 0.09 TECH SHC: -, -, -, 4.03, 2.97, 5.55, 5.02, 5.49, 3.53, - SHC CAI: -, -, -, -, -, -, -, n/m, 0.66, - CAI CORT: 0.00, -, -, -, -, -, -, -, -, - CORT BCRX: 0.27, 0.61, 1.31, n/m, n/m, n/m, n/m, n/m, n/m, - BCRX IONS: -, -, 0.54, 1.13, -, 2.08, 3.38, 2.13, 3.71, - IONS PBH: 2.67, 1.69, 1.64, 1.48, 1.09, 0.94, 0.93, 0.68, 0.54, 0.53 PBH
PBH is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 0.00 to 5.55. A gap is a year with no number. A ring marks where a line starts: SHC, CAI, IONS have no earlier 10-K here.
CompanyFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
PBH Mar 2.671.691.641.481.090.940.930.680.540.53
ACAD Dec ----------
TECH Jun 0.360.310.430.260.220.150.180.150.180.09
SHC Dec ---4.032.975.555.025.493.53-
GH Dec -------n/mn/m-
CAI Dec -------n/m0.66-
PGNY Dec -n/m--------
CORT Dec 0.00---------
BCRX Dec 0.270.611.31n/mn/mn/mn/mn/mn/m-
IONS Dec --0.541.13-2.083.382.133.71-
Peer median0.27-0.541.13-2.083.382.132.09-

EPS (diluted), FY2017 to FY2026

Diluted earnings per share, on today's share count after splits.

−$940.00 $6.34 FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026 ACAD: −$2.36, −$1.94, −$1.60, −$1.79, −$1.05, −$1.34, −$0.37, $1.36, $2.30, - ACAD TECH: $0.51, $0.83, $0.62, $1.46, $0.87, $1.66, $1.76, $1.05, $0.46, $1.16 TECH SHC: -, -, −$0.09, −$0.16, $0.41, −$0.83, $0.18, $0.16, $0.27, - SHC GH: −$7.07, −$2.80, −$0.84, −$2.60, −$4.00, −$6.41, −$4.28, −$3.56, −$3.32, - GH CAI: -, -, -, -, -, -, −$13.24, −$10.66, −$3.22, - CAI PGNY: −$2.37, $0.04, −$0.41, $0.47, $0.66, $0.30, $0.62, $0.57, $0.65, - PGNY CORT: $1.04, $0.60, $0.77, $0.85, $0.89, $0.87, $0.94, $1.23, $0.82, - CORT BCRX: −$0.78, −$0.98, −$940.00, −$1.09, −$1.03, −$1.33, −$1.18, −$0.43, $1.21, - BCRX IONS: $0.15, $2.07, $1.90, −$3.18, −$0.20, −$1.90, −$2.56, −$3.04, −$2.38, - IONS PBH: $1.30, $6.34, −$0.69, $2.78, $3.25, $4.04, −$1.65, $4.17, $4.29, $3.91 PBH
PBH is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$940.00 to $6.34. A gap is a year with no number. A ring marks where a line starts: SHC, CAI have no earlier 10-K here.

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out PBH and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more

Sources

Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.

Also

Financials: PBH's own statements, year by year. Compare: the whole peer group on one page.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PBH/export.csv") into a cell.

Next:Industry numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.